SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors aggressively bid up shares amidst a perceived supply bottleneck, fueled by labor disputes at Samsung and sustained demand for AI-driven memory infrastructure. The community remains sharply divided, with bulls pointing to a rerating of the stock's valuation and potential for further gains, while bears argue the parabolic move is an overextended bubble driven by sentiment rather than fundamentals.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares are seeing significant volatility following a Q1 earnings report that missed revenue and EPS expectations, shifting investor focus toward the company's ambitious satellite deployment timeline and cash burn rate. While some in the community argue that current financials are secondary to the long-term potential of the firm's direct-to-device infrastructure, bears are aggressively highlighting launch execution risks and the company's inability to consistently meet its growth targets.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is seeing heightened activity as market participants speculate on a potential breakout driven by tight industrial supply chains and increased demand for precious metals in AI infrastructure. Community sentiment remains deeply divided, with bulls pointing to historical supply deficits and long-term storage potential, while others caution that the asset's recent volatility is heavily influenced by geopolitical headlines and macro-correlations with oil and the dollar.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing heightened investor activity following a significant stock price correction after earnings, with the community actively debating whether this is a temporary dip or a sign of deeper management and guidance issues. Long-term bulls are viewing the current valuation as a prime entry point, emphasizing the upcoming product launches and the potential for a long-term rally despite frustration over short-term execution.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is experiencing significant volatility as investors weigh a recent defense contract against ongoing skepticism regarding the company's edge AI performance benchmarks. The community remains sharply divided between those betting on long-term disruption in the defense and autonomous drone sectors and those highlighting concerns over transparency and the long-term viability of their compute-in-memory architecture.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

High-Trend International Group is experiencing extreme volatility and massive volume spikes driven by speculative momentum, leading to intense community debate over whether it is a legitimate short squeeze or a classic pump-and-dump scheme. Investors are closely monitoring its price action and halt status, with many actively discussing the risks and potential for rapid reversals common in low-float, China-based stocks.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop shares are experiencing extreme volatility and intense community speculation following a confusing sequence of social media activity and a proxy statement proposing a massive increase in authorized shares. Investors are actively debating whether these maneuvers are strategic steps toward a potential acquisition of eBay or a move that will lead to significant shareholder dilution.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as investors react to a significant GPO agreement that expands insurance coverage for its fibromyalgia treatment, TONMYA, to 35 million lives. While some in the community highlight this as a long-awaited commercial catalyst and point to growing script volume as evidence of progress, others remain skeptical, focusing on the company's high cash burn rate, potential for future dilution, and recurring shareholder frustration regarding management's history with reverse stock splits.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is facing heightened market scrutiny surrounding its upcoming earnings report, with sentiment divided between concerns over past performance and optimism regarding the potential passage of the CLARITY Act. Traders are actively debating whether the stock's recent volatility is a setup for a breakout driven by regulatory catalysts or if the company will continue to struggle with cooling crypto trading volumes.

Roundhill ETF Trust - Roundhill Memory ETF

Roundhill Memory ETF (DRAM) is surging as a core AI infrastructure play, driven by an intensifying global shortage of memory chips and aggressive capital investment by hyperscalers. The community is heavily focused on the stock's structural role in the AI supercycle, with discussions centering on the long-term supply bottleneck and the difficulty of accessing top-tier South Korean memory producers without this ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates

Metagenomi Therapeutics (MGX) delivered earnings and revenue surprises of -2.52% and -68.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +26.03% and -10.73%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Metagenomi (MGX) Projected to Post Quarterly Earnings on Tuesday

Metagenomi (NASDAQ:MGX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-metagenomi-inc-stock...

Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five ratings firms that are presently covering the stock, MarketBeat reports. One...

Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW...

Metagenomi (MGX) to Release Earnings on Wednesday

Metagenomi (NASDAQ:MGX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...

Wall Street Zen Downgrades Metagenomi (NASDAQ:MGX) to Sell

Wall Street Zen cut Metagenomi from a "hold" rating to a "sell" rating in a report on Saturday...

Metagenomi, Inc. (NASDAQ:MGX) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a buy rating...

Metagenomi (MGX) Projected to Post Quarterly Earnings on Monday

Metagenomi (NASDAQ:MGX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 16. (View Earnings Report at...

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Metagenomi Therapeutics (MGX) delivered earnings and revenue surprises of -4.35% and -54.84%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Current Price	$1.35
Prev Close	$1.41
Open	$1.39
Dividend Yield	0.00%
50-Day Moving Average	$1.44
Beta	1.17
Avg. Volume	177,447.17
PE Ratio	-0.57

52-Week High	$3.95
52-Week Low	$1.25
Market Capitalization	$53.04M
EPS (Annual)	-$2.36
Price to Book	0.32
Revenue Per Employee	$211,848.74

MGX
Metagenomi Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MGX News

MGXMetagenomi Inc.